Effects of Carnitine Supplementation on Exercise-Induced Muscle Damage: A Randomized Controlled Trial

Istanbul Sabahattin Zaim University

Status: Completed

Conditions: Carnitine Ingestion; Exercise Fatigue; Recovery Methods; Exercise and Recovery; Exercise Ergogenics

Treatments: Other: Placebo; Dietary Supplement: L-Carnitine

Study type: Interventional

Funder types: Other

Identifiers

NCT07492446

E-95961207-604.01.01-2245

Kutahya Dumlupınar University (Other Identifier)

Details and patient eligibility

About

This clinical study aims to investigate the effects of L-carnitine supplementation on recovery following high-intensity interval exercise in young athletes. L-carnitine plays an important role in energy metabolism by facilitating the transport of long-chain fatty acids into the mitochondria for oxidation. It has been suggested that L-carnitine supplementation may contribute to improved exercise performance and recovery by reducing metabolic stress and muscle damage associated with high-intensity exercise.

The primary objective of this study is to determine whether L-carnitine supplementation can attenuate exercise-induced muscle damage and delayed onset muscle soreness (DOMS) following high-intensity exercise. In addition, the study aims to evaluate the potential effects of L-carnitine on peak blood lactate concentration, as well as performance-related parameters including maximal power output, relative maximal power output, mean power output, and relative mean power output during high-intensity exercise.

To address these objectives, participants will be randomly assigned to receive either L-carnitine supplementation or a placebo for a period of 21 days. The placebo will consist of an inert substance designed to resemble the supplement but without any active ingredient. The effects of supplementation on performance and recovery outcomes will be evaluated following a standardized high-intensity exercise protocol.

Participants will be instructed to take the assigned supplement daily throughout the supplementation period. Communication and compliance monitoring will be conducted through a WhatsApp group established by the research team, which will be used to provide reminders and ensure adherence to the study protocol.

To minimize potential confounding factors related to pre-existing muscle damage, participants will be instructed to avoid unfamiliar or strenuous physical activity, particularly resistance exercises involving eccentric contractions, for one week prior to the experimental protocol. Additionally, during the supplementation period, participants will be asked to refrain from consuming foods rich in carnitine, such as meat and dairy products, in order to control dietary carnitine intake.

The findings of this study are expected to provide further insight into the potential role of L-carnitine supplementation in enhancing exercise performance and promoting recovery following high-intensity exercise in young athletes.

Enrollment: 30 patients

Sex: Male

Ages: 18 to 25 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Male athletes aged 18-25 years
• Regularly participating in organized sports training for at least 3 days per week
• Healthy individuals with no diagnosed cardiovascular, metabolic, or musculoskeletal disorders
• Willingness to comply with the supplementation protocol for 21 days
• Agreement to refrain from consuming foods rich in carnitine (e.g., meat and dairy products) during the supplementation period
• Agreement to avoid unfamiliar or strenuous exercise, particularly resistance exercise involving eccentric contractions, for one week prior to the experimental protocol
• Provision of written informed consent to participate in the study

Exclusion criteria

• Use of dietary supplements (including L-carnitine) within the last 3 weeks
• Presence of musculoskeletal injury or chronic disease that may affect exercise performance
• Use of medications that may influence muscle metabolism or recovery
• Known allergy or intolerance to the supplement components
• Failure to comply with the dietary or supplementation protocol
• Participation in another clinical or exercise intervention study during the study period
• Any condition deemed unsuitable for participation by the research team

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

30 participants in 2 patient groups, including a placebo group

L-Carnitine Supplementation Group

Experimental group

Description:

Participants in this group will receive L-carnitine supplementation for 21 days prior to completing a standardized high-intensity interval exercise protocol. The effects of supplementation on exercise-induced muscle damage, recovery, blood lactate levels, and anaerobic performance will be evaluated.

Treatment:

Dietary Supplement: L-Carnitine

Placebo Group

Placebo Comparator group

Description:

Participants in this group will receive a placebo supplement identical in appearance to the L-carnitine supplement for 21 days prior to the high-intensity interval exercise protocol.

Treatment:

Other: Placebo